News & Updates

Households, and not schools, are the major route of coronavirus disease 2019 (COVID-19) transmission for those ≤18 years of age, according to a cross-sectional study of nearly 400 Hong Kong children and youths who contracted COVID-19 in 2020.

Functional abdominal pain among inflammatory bowel disease children in remission (IBP-FAPD) is common and leads to worse fatigue and lower health-related quality of life (HR-QoL), a recent study has found. Past disease severity does not significantly predict IBP-FAPD.

Prompt empiric antiviral treatment in children hospitalized for influenza and with high-risk medical conditions or in children admitted to an intensive care unit (ICU) leads to early discharge, as shown in a study.

Treatment with delgocitinib ointment, a topical Janus kinase (JAK) inhibitor, for paediatric atopic dermatitis (AD) is effective and well tolerated when applied for up to 56 weeks, according to a phase III trial and a subsequent open-label, long-term study in Japan.

A large international database study has shown that children and adolescents with cancer have an elevated risk of severe or critical disease if infected with COVID-19. Furthermore, about half the patients receiving cancer therapy experienced modifications to their treatment regimens. 

Paediatric patients with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) may develop acute abdomen, with or without appendicitis, a study in Latin America has found.

Individuals who had been exposed to upper respiratory tract infection (URTI) and antibiotics as a child are at heightened risks of atopic dermatitis and allergic skin diseases in their young adulthood, as reported in a study.